Search - tctmd.com

Displaying 401 - 420 of 629

Sort: Relevancy | Date

News Opinion CV Team Dispatch

May 2021 News Roundup

L.A. McKeown

May 01, 2021

News Daily News

New HF Uncommon After COVID-19, but Rare Cases Pose Quandary

Shelley Wood

April 28, 2021

News Daily News

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Michael O'Riordan

April 26, 2021

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

News Daily News

Pneumonia in HF Patients Is Common, Lethal, and Preventable

L.A. McKeown

April 19, 2021

News Daily News

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

Michael O'Riordan

April 15, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2021

Shelley Wood

April 02, 2021

News Daily News

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Michael O'Riordan

April 02, 2021

News Daily News

Women Treated for Acute HF Report Worse QoL Than Men

Caitlin E. Cox

March 12, 2021

News Daily News

Cardiometabolic Diseases Contribute to Bulk of COVID-19 Hospitalizations

Todd Neale

March 04, 2021

News Opinion CV Team Dispatch

March 2021 News Roundup

L.A. McKeown

March 01, 2021

News Daily News

High Glycemic Index Diets Linked to CVD and Mortality

Michael O'Riordan

February 24, 2021

News Daily News

Women’s Risk for CVD Seen at Lower BP Thresholds Than Men

L.A. McKeown

February 24, 2021

News Daily News

New FDA Indication Opens Up Use of Sacubitril/Valsartan in HFpEF

Todd Neale

February 16, 2021

News Daily News

CABANA Supports Use of AF Ablation in Patients With Heart Failure

Todd Neale

February 12, 2021

News Opinion CV Team Dispatch

February 2021 News Roundup

L.A. McKeown

February 01, 2021

News Daily News

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Michael O'Riordan

January 28, 2021

News Daily News

FDA Approves Vericiguat for High-risk Patients With HF

Michael O'Riordan

January 20, 2021

News Daily News

Hospitalization for HF After Acute MI More Common in Women Than Men

L.A. McKeown

January 15, 2021

News Daily News

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

L.A. McKeown

January 11, 2021

Advertisement

May 2021 News Roundup

New HF Uncommon After COVID-19, but Rare Cases Pose Quandary

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Pneumonia in HF Patients Is Common, Lethal, and Preventable

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

TCTMD’s Top 10 Most Popular Stories for March 2021

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Women Treated for Acute HF Report Worse QoL Than Men

Cardiometabolic Diseases Contribute to Bulk of COVID-19 Hospitalizations

March 2021 News Roundup

High Glycemic Index Diets Linked to CVD and Mortality

Women’s Risk for CVD Seen at Lower BP Thresholds Than Men

New FDA Indication Opens Up Use of Sacubitril/Valsartan in HFpEF

CABANA Supports Use of AF Ablation in Patients With Heart Failure

February 2021 News Roundup

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

FDA Approves Vericiguat for High-risk Patients With HF

Hospitalization for HF After Acute MI More Common in Women Than Men

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content